• Conference
  • Earn CE
  • Free Samples
  • Magazine
  • Subscribe
  • Videos
    • Recent Quotes
    My Watchlist
    Indicators
    Dental Market Index
    Markets
    Stocks
    ETFs
    Tools
    Overview
    News
    Currencies
    International
    Treasuries

    Pulmonx Corp (NQ: LUNG )

    7.440 +0.080 (+1.09%)
    Streaming Delayed Price Updated: 4:00 PM EST, Nov 8, 2024 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    Press Releases about Pulmonx Corp

    < Previous 1 2 Next >
    Pulmonx to Participate in the Canaccord Genuity MedTech, Diagnostics and Digital Health & Services Forum
    From Pulmonx Corporation
    Via GlobeNewswire
    Pulmonx to Present at the Stifel 2024 Healthcare Conference
    From Pulmonx Corporation
    Via GlobeNewswire
    Pulmonx Reports Third Quarter 2024 Financial Results
    From Pulmonx Corporation
    Via GlobeNewswire
    Pulmonx to Report Third Quarter 2024 Financial Results on October 30, 2024
    From Pulmonx Corporation
    Via GlobeNewswire
    Pulmonx Announces Presentation of Clinical Data from the AeriSeal® CONVERT Trial and 5-Year Follow-up Data from the LIBERATE Study at the European Respiratory Society Congress 2024
    From Pulmonx Corporation
    Via GlobeNewswire
    Pulmonx to Participate in the Lake Street 8th Annual Best Ideas Growth Conference
    From Pulmonx Corporation
    Via GlobeNewswire
    Pulmonx to Present at the 2024 Wells Fargo Healthcare Conference
    From Pulmonx Corporation
    Via GlobeNewswire
    Pulmonx Reports Second Quarter 2024 Financial Results
    From Pulmonx Corporation
    Via GlobeNewswire
    Pulmonx to Present at the Canaccord Genuity 44th Annual Growth Conference
    From Pulmonx Corporation
    Via GlobeNewswire
    Pulmonx to Report Second Quarter 2024 Financial Results on July 31, 2024
    From Pulmonx Corporation
    Via GlobeNewswire
    Pulmonx Announces Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
    From Pulmonx Corporation
    Via GlobeNewswire
    Pulmonx Reports First Quarter 2024 Financial Results
    Achieves 30% year-over-year worldwide revenue growth 
    From Pulmonx Corporation
    Via GlobeNewswire
    Pulmonx to Report First Quarter 2024 Financial Results on May 1, 2024
    From Pulmonx Corporation
    Via GlobeNewswire
    Pulmonx Announces Appointment of Mehul Joshi as Chief Financial Officer
    From Pulmonx Corporation
    Via GlobeNewswire
    Pulmonx Announces Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
    From Pulmonx Corporation
    Via GlobeNewswire
    Pulmonx Announces Treatment of the First Patient with the AeriSeal® System in CONVERT II Pivotal Trial
    From Pulmonx Corporation
    Via Business Wire
    Pulmonx Reports Fourth Quarter and Full Year 2023 Financial Results
    From Pulmonx Corporation
    Via GlobeNewswire
    Pulmonx Announces Retirement of CEO Glen French and Appointment of Industry Veteran Steve Williamson as President and Chief Executive Officer
    From Pulmonx Corporation
    Via GlobeNewswire
    Pulmonx to Report Fourth Quarter and Full Year 2023 Financial Results on February 21, 2024
    From Pulmonx Corporation
    Via GlobeNewswire
    The Honest Company Announces Appointment of Michael Barkley, Alissa Hsu Lynch, and Andrea Turner to the Board of Directors
    From The Honest Company, Inc.
    Via GlobeNewswire
    Pulmonx to Present at the Piper Sandler 35th Annual Healthcare Conference
    From Pulmonx Corporation
    Via GlobeNewswire
    Pulmonx to Participate at Upcoming Investor Conferences
    From Pulmonx Corporation
    Via GlobeNewswire
    Pulmonx Reports Record Third Quarter 2023 Financial Results
    From Pulmonx Corporation
    Via GlobeNewswire
    Pulmonx to Report Third Quarter 2023 Financial Results on October 30, 2023
    From Pulmonx Corporation
    Via GlobeNewswire
    Pulmonx Announces CFO Transition and Record Preliminary Third Quarter 2023 Revenue
    From Pulmonx Corporation
    Via GlobeNewswire
    Pulmonx to Participate at Upcoming Investor Conferences
    From Pulmonx Corporation
    Via GlobeNewswire
    Pulmonx Reports Second Quarter 2023 Financial Results
    From Pulmonx Corporation
    Via GlobeNewswire
    Pulmonx to Present at the Canaccord Genuity 43rd Annual Growth Conference
    From Pulmonx Corporation
    Via GlobeNewswire
    Pulmonx to Report Second Quarter 2023 Financial Results on August 2, 2023
    From Pulmonx Corporation
    Via GlobeNewswire
    Pulmonx Reports First Quarter 2023 Financial Results
    From Pulmonx Corporation
    Via GlobeNewswire
    < Previous 1 2 Next >
    Data & News supplied by www.cloudquote.io
    Stock quotes supplied by Barchart
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the following
    Privacy Policy and Terms and Conditions.